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Toll-like receptor 4 signalling through MyD88 is essential to control
Salmonella enterica serovar Typhimurium infection, but not for the
initiation of bacterial clearance
Introduction
Systemic infection of mice with Salmonella enterica serovar
Typhimurium (S. Typhimurium) causes a disease similar
in many respects to typhoid fever in humans.1 The immune
responses to systemic sublethal S. Typhimurium infection
are well characterized and this is therefore a valuable model
for using to understand how different immune mechanisms
contribute to the control of Salmonella infections and for
studying how an immune response to infection develops
in vivo. In a systemic infection the bacteria reside and
replicate within phagocytes.2 During the first few hours of
systemic disease there is a decrease in bacterial numbers
that is dependent on bacterial killing by neutrophil and
macrophage nicotinamide adenine dinucleotide phosphate
(NADPH)-oxidase activity in the context of prevention of
bacterial growth through natural resistance-associated
macrophage protein (NRAMP)-1/Slc11a1 activity.2,3 Dur-
ing the next few days of systemic infection, exponential
growth of S. Typhimurium occurs, the rate of which
depends on the virulence of the bacterial strain and the
genetic background of the host. This growth may, in turn,
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Summary
Toll-like receptor-4 (TLR4) is important in protection against lethal
Salmonella enterica serovar Typhimurium (S. Typhimurium) infection.
Control of the early stages of sublethal S. Typhimurium infection in mice
depends on TLR4-dependent activation of macrophages and natural killer
(NK) cells to drive an inflammatory response. TLR4 signals through the
adapter proteins Mal/MyD88 and TRIF-related adaptor molecule
(TRAM)/TIR-domain-containing adaptor-inducing interferon-b (TRIF). In
the mouse typhoid model we showed that TLR4 and MyD88, but not Mal
or TRIF, are essential for the control of exponential S. Typhimurium
growth. TRIF)/) mice have a higher bacterial load in comparison with
wild-type mice during a sublethal infection because TRIF is important for
bacterial killing during the first day of systemic disease. Minimal pro-
inflammatory responses were induced by S. Typhimurium infection of
macrophages from TLR4)/), MyD88)/) and TRIF)/) mice in vitro. Pro-
inflammatory responses from Mal)/) macrophages were similar to those
from wild-type cells. The pro-inflammatory responses of TRIF)/) macro-
phages were partially restored by the addition of interferon-c (IFN-c), and
TRIF)/) mice produced markedly enhanced IFN-c levels, in comparison
to wild-type mice, probably explaining why bacterial growth can be con-
trolled in these mice. TLR4)/), MyD88)/), TRIF)/) and Mal)/) mice all
initiated clearance of S. Typhimurium, suggesting that TLR4 signalling is
not important in driving bacterial clearance in comparison to its critical
role in controlling early bacterial growth in mouse typhoid.
Keywords: Mal; MyD88; Salmonella; toll-like receptor; TLR4; TRIF
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be controlled by macrophages and natural killer (NK) cells
releasing cytokines to induce an inflammatory response.2
This control of S. Typhimurium growth has been referred
to as the plateau phase.4 Initiation and expansion of T
helper 1 (Th1)-type T-cell immunity is required for the late
phase of control and eventual clearance of the infection.2
Pro-inflammatory cytokines that are produced by the host
in response to systemic S. Typhimurium infection are
therefore critical for the control of bacterial growth.2
Initial host recognition of S. Typhimurium infection
depends on pattern recognition receptors (PRRs), in particu-
lar during systemic infection, on toll-like receptor (TLR)4;5–
9 however, TLR2 is important in the later stages of lethal
infection models.10 Lipopolysaccharide (LPS) expressed by
S. Typhimurium is recognized by TLR4, in association with
MD2 and CD14.6,11 TLR4 recognition of S. Typhimurium
activates macrophages, initiating the oxidative burst and
inducing cytokine production. TLR4 signals via recruitment
of at least four adapter proteins: MyD88, Mal, TRIF-related
adaptor molecule (TRAM) or TIR-domain-containing adap-
tor-inducing interferon-b (TRIF).12 TLR4/Mal/MyD88 sig-
nalling induces cytokines such as tumour necrosis factor-a
(TNF-a), interleukin (IL)-6 and IL-12p40, whereas signalling
through TLR4/TRAM/TRIF also induces Type I interferon
(IFN)-dependent proteins such as IFN-b, regulated on acti-
vation, normal, T-cell expressed, and secreted (RANTES)
and IL-12p35.12 Cytokines are required for granuloma for-
mation and for activation of inducible nitric oxide synthase
(iNOS)-dependent antibacterial functions of macrophages
during the plateau phase.2
TLR2 has a limited role in the early control of S. Typhimu-
rium infection,6–9 but is important in protection against
lethal sepsis driven by both Gram-positive13 and Gram-nega-
tive10 bacteria. The roles of TLR4 and TLR2 in protecting
mice against lethal infection with S. Typhimurium are
clear,5,8,10,14,15 but much less is known about how these
receptors and their signalling pathways are involved in the
immune responses that control and clear Salmonella infec-
tions. In LPS-resistant mice (C3H/HeJ; with mutated, non-
signalling TLR4) the plateau phase does not occur, indicating
that control of bacterial growth is dependent on the inflam-
matory response induced by TLR4 recognition of LPS.2,5,8,9
It is critical to understand the immune mechanisms involved
in the control and clearance of bacteria if successful manage-
ment of invasive salmonellosis is to be achieved.
Here we have studied how TLR2, TLR4, MyD88, Mal
and TRIF influence plateau formation during the suble-
thal infection of mice with S. Typhimurium. We showed
that TLR4 and MyD88, but not TLR2, Mal or TRIF, are
essential for plateau formation, whereas TRIF is involved
in the early phase of bacterial killing. By comparison,
whilst TLR4 is critical for driving the plateau phase in
S. Typhimurium growth, TLR4-dependent signalling
seems to be much less important in initiating the clear-
ance phase of this bacterial infection.
Materials and methods
Mouse strains
Mice were bred under specific pathogen-free conditions at
Harlan, Loughborough, UK or in the Department of Veter-
inary Medicine, the University of Cambridge (Cambridge,
UK). Mice were housed in isolators or in filter-top cages
and were provided with sterile water and food ad libitum.
TLR4)/),16 TLR2)/),17 TLR2)/) TLR4)/),8 MyD88)/),18
Mal)/),19 and TRIF)/)20 mice on a C57BL/6 background
were as described previously. C57BL/6 mice were pur-
chased from Harlan, UK.
Bacterial strains and ligands
Infection studies in vivo were performed using S.
Typhimurium M525P, a strain that establishes sublethal
infection in immunocompetent C57BL/6 mice, but is vir-
ulent enough to cause rapidly lethal infections in animals
with impaired innate resistance and/or adaptive
responses.7,21 To determine whether effective Th1
responses can be generated in TLR4)/) and MyD88)/)
mice we used S. Typhimurium SL3261, which is an
attenuated mutant that causes slowly progressive lethal
infections if the animals fail to mount T-cell immunity.22
In the macrophage experiments, virulent, wild-type
S. Typhimurium SL1344 was used for all experiments.
S. Typhimurium strain SL1344 LPS was a generous gift from
Anjam Khan (University of Newcastle, Newcastle, UK).
Infection of mice
Bacteria were grown overnight at 37 as a static culture
in Luria–Bertani (LB) medium. Bacteria were washed
and diluted in phosphate-buffered saline (PBS) to
obtain 5 x 103 colony-forming units (CFU)/ml. Unless
otherwise stated, 200 ll (103 CFU) of this bacterial sus-
pension was injected into the tail vein. Appropriate
dilutions of the inoculum were plated onto LB agar for
precise enumeration of the number of viable bacteria
given to the mice. At each time-point after infection,
mice were killed by cervical dislocation and spleens and
livers were removed. The organs were placed into
10 ml of sterile distilled water and homogenized in a
Colworth Stomacher (Sewerd Ltd, Worthing, UK) for
subsequent determination of viable bacterial counts by
plating out appropriate dilutions of the homogenates
onto LB agar. Viable CFU isolated per liver for individ-
ual mice are shown.
Preparation of livers for histological analysis
Livers were fixed in 10% formalin and then prepared
for standard paraffin embedding and sectioning. Three-
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micrometer sections of liver from each mouse were
stained with haematoxylin and eosin for histological
analysis. Analyses were performed by one investigator
(KH) who was blinded to the genotype of the mouse
and to the experimental conditions. Quantitative assess-
ment of liver lesions was undertaken by counting the
number of liver inflammatory lesions per 10 high-
power fields (·400 magnification) of hepatic paren-
chyma. Qualitative evaluation of lesion architecture was
also undertaken.
Infection of bone marrow macrophages
Primary bone marrow-derived macrophages (BMDMs)
were isolated from femurs and tibiae of mice killed by
cervical dislocation, then cultured in BMDM medium
[RPMI-1640 medium supplemented with 10 % (v/v) fetal
calf serum, 2 mM glutamine, 5 % (v/v) horse serum,
1 mM sodium pyruvate and 10 lg/ml of gentamicin], in
petri dishes. To isolate BMDM from MyD88 mice, femurs
from knockout and wild-type mice were shipped on ice
from Dr K. Fitzgerald (University of Massachusetts Medi-
cal School, Worcester, MA, USA). For maintenance of
BMDMs in culture this medium was further supple-
mented with 20% (v/v) supernatant taken from L929 cells
(a murine macrophage colony-stimulating factor
producing cell line).6,23 For experiments, cells were plated
onto 96-well plates at a plating density of 2 · 105 cells
per well, in the absence of gentamicin.
S. Typhimurium SL1344 in mid-log phase was added
to the cells at multiplicities of infection (MOI) of 1 or 10.
Following a 2 hr incubation, the cells were incubated in
BMDM medium containing 50 lg/ml of gentamicin for
1 hr to kill extracellular Salmonella. Cells were then incu-
bated in BMDM medium containing 10 lg/ml of genta-
micin until the end of the experiment.
We used the S. Typhimurium strain SL1344 for our in vi-
tro experiments to ensure that our data were comparable
with other published data on S. Typhimurium infections
in vitro.8,24–26 In our preliminary analysis comparing the
in vitro response of SL1344 and M525P strains in wild-type,
TLR4)/) and MyD88)/) BMDMs we saw similar levels of
TNF-a and slightly lower levels of nitric oxide (NO) in
response to SL1344. The effect of the gene knockouts on the
macrophage response was identical for both bacterial
strains.
Measurement of TNF-a production
To determine cumulative TNF-a production, supernatants
were obtained 7 hr after infection (cumulative 3–7 hr
after infection) and stored at )80 until analysed using
the Duoset enzyme-linked immunosorbent assay
(ELISA) development system (R&D Systems, Abingdon,
Oxfordshire, UK).
Measurement of NO production
iNOS activity was determined indirectly using samples of
supernatant taken 22 hr after infection and stored at
)20. Nitrite accumulation was measured using the Griess
reaction as an indication of iNOS activity.27
Splenocyte cytokine measurements
Splenocytes were isolated from mice infected with S. Ty-
phimurium. The spleens were removed aseptically and
passed through a 40-lm nylon strainer to yield spleno-
cytes. These were washed, then red blood cells were lysed
by incubation with Gey’s solution for 3 min, and plated
at 1 · 106 cells/well in a 96-well plate in RPMI-1640 con-
taining 10% (v/v) fetal calf serum (FCS), 1 mM HEPES,
5 mM L-glutamine, 2 · 10)5 M b-mercaptoethanol, 100 U/
ml of penicillin and 100 lg/ml of streptomycin. Spleno-
cytes were stimulated with S. Typhimurium strain M525P
grown to mid-log phase at an MOI of 1:1 or stimulated
with LPS (1 lg/ml; from S. Typhimurium SL1344). Sam-
ples of supernatant were taken 6 and 24 hr later and
assayed for TNF-a, or were taken 48 hr later and assayed
for IFN-c. Samples were stored at )80 until assayed
using the Duoset ELISA development system (R&D Sys-
tems) for IFN-c or TNF-a.
Statistical analysis
Statistical analysis was performed using a two-way analy-
sis of variance (ANOVA) followed by Bonferonni post-test-
ing. A Mann–Whitney U-test was performed on data
pooled from two or more in vivo infections. Histological
analysis was compared using a Student’s t-test. Statistical
differences are given by asterisks as follows: *P < 005,
**P < 001, ***P < 0001.
Results
TLR4, but not TLR2, is required to control the
growth of a sublethal systemic infection of
S. Typhimurium in vivo
Mice were infected with 200 ll (103 CFU) of S. Typhimu-
rium M525P and bacterial counts were measured in the
livers and spleens from these animals. In wild-type mice,
as expected, there was a drop in bacterial numbers of
approximately half a log within the first day of infection.4
After this, the growth of S. Typhimurium in liver and
spleen was exponential until it plateaued at day 3 postin-
fection (Fig. 1, spleen data not shown). The plateau was
sustained for the duration of the short-term experiment.
In TLR4)/) mice, higher bacterial numbers were seen on
day 1 postinfection and then, similarly to what is seen in
C3H/HeJ mice,5 bacterial growth increased more rapidly
474  2009 Blackwell Publishing Ltd, Immunology, 128, 472–483
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than in wild-type controls, at approximately 1 log per
day, until the experiment was stopped because an over-
whelming bacterial load had caused the mice to become
terminally ill (Fig. 1) [Analysis of the combined results
from two separate experiments using the Mann–Whitney
U-test found that bacterial burdens in the TLR4)/) mice
were significantly higher at all the time-points shown
(P < 001 at day 1 and P < 0001 at days 3 and 5 post-
infection)]. TLR4 is therefore essential for both the con-
trol of the initial growth rate of S. Typhimurium and for
plateau formation to occur. The growth of S. Typhimuri-
um in TLR2)/) mice was identical in both liver and
spleen to what is seen in the wild-type mice (Fig. 1,
spleen data not shown) (No significant increase in bacte-
rial burdens were found in the TLR2)/) mice when the
data from two experiments were pooled). We infected
mice with higher numbers of bacteria (104 CFU) to see if
this would reveal any role for TLR2 in controlling S. Ty-
phimurium in vivo, but bacterial growth was again similar
to that seen in wild-type animals, suggesting that TLR2
does not play a role in controlling S. Typhimurium
growth in sublethal infection (data not shown). In a preli-
minary experiment, where we infected TLR2)/) TLR4)/)
double knockout mice, there was no difference in bacte-
rial counts from those seen during infection of TLR4)/)
mice, suggesting that TLR2 is unimportant, in compari-
son to TLR4, for the control of sublethal bacterial growth
in the spleen and liver (data not shown).
The macrophage pro-inflammatory response to
S. Typhimurium infection is absent in cells from
TLR4)/) mice
The generation of a pro-inflammatory response to S. Typhi-
murium is required in order for the host to control
bacterial growth. Activation of TLR4 by S. Typhimurium
induces the production of pro-inflammatory cytokines,
such as TNF-a, and inflammatory proteins, such as iNOS.6
To confirm that TLR4 activation by S. Typhimurium was
driving a pro-inflammatory response, we infected BMDMs
from wild-type and TLR4)/) mice with this bacterium and
measured TNF-a production after 7 hr and NO production
at 22 hr. Wild-type BMDMs produced a robust inflamma-
tory response to infection, but the TLR4)/) BMDMs, as
expected, produced little TNF-a or NO (Fig. 1c,d).
MyD88, but not Mal or TRIF, is essential for
establishing the plateau phase in controlling the
growth of sublethal infection of mice with
S. Typhimurium
The essential role of TLR4 in controlling bacterial growth
led us to investigate the contribution of both the MyD88
and TRIF signalling pathways in mouse typhoid. In
MyD88)/) mice, exponential bacterial growth continued
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Figure 1. Bacterial counts after intravenous infection of mice with
1 · 103 colony-forming units (CFU)/mouse of Salmonella enterica ser-
ovar Typhimurium (S. Typhimurium) M525P. Mice were killed by
cervical dislocation, bacterial loads were determined in the liver and
the results are expressed as log CFU per organ for each mouse with the
mean marked by a bar. Wild-type (WT), toll-like receptor (TLR)4)/)
(n = 4) (a) or TLR2)/) (n = 3) (b) mice were infected and the results
shown are representative of at least two separate experiments. Bone
marrow-derived macrophages (BMDMs) from WT and TLR4)/) mice
were infected with S. Typhimurium strain SL1344 at a multiplicity of
infection (MOI) of 0:1, 1:1 or 10:1 (bacteria : cell). Supernatant sam-
ples were analysed by enzyme-linked immunosorbent assay (ELISA)
for tumour necrosis factor-a (TNF-a) 7 hr after infection (n = 4) (c)
and for nitrite accumulation by the Griess reaction 22 hr after infec-
tion (n = 6) (d). The results are expressed as mean ± standard devia-
tion, **P < 001, ***P < 0001. p.i., postinfection.
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unchecked, in a similar manner to that seen in the
TLR4)/) animals, and the mice were unable to mount an
effective response to control the growth of S. Typhimuri-
um (Fig. 2a) [a significantly higher (P < 001) bacterial
burden was observed in the MyD88)/) mice on days 3
and 5 when the combined results from two experiments
were analysed]. MyD88 is therefore essential for establish-
ment of the plateau phase of bacterial growth.
The importance of TLR4 and MyD88 in controlling
bacterial growth suggested that TLR4 signalling through
the TRIF pathway was likely to be less important in driv-
ing host responses to S. Typhimurium. TRIF)/) mice
infected with S. Typhimurium, however, showed higher
bacterial counts by day 1 in comparison to infected wild-
type mice (Fig. 2b). We studied bacterial growth over a
short time course and found that this difference in bacte-
rial counts was apparent [and statistically significant
(P < 0001) when pooling results from two separate
experiments] by 4 hr (Fig. 2d). After day 1, however, the
rates of bacterial growth in livers and spleens were very
similar to those seen in the wild-type animals. This meant
that the TRIF)/) animals had a consistently higher bacte-
rial burden, at each time-point, of 04–12 log CFU/spleen
or of 08–16 log CFU/liver (Fig. 2b) [values determined
from data pooled from five separate experiments, which
found that the bacterial burdens in the TRIF)/) mice
were significantly higher (P < 0001) than in the wild-
type mice on days 1, 4 and 7 postinfection]. TRIF)/) mice
are therefore able to control sublethal infection with
S. Typhimurium, but achieve the plateau phase at a
higher bacterial burden than the wild-type mice.
Finally, Mal)/) mice were infected with S. Typhimurium
and, surprisingly, unlike TLR4)/) and MyD88)/) mice, the
Mal)/) mice controlled the infection in a manner similar
to that of wild-type mice (Fig. 2c). By 7 days postinfection
the bacterial load in the Mal)/) mice was significantly
higher than in the wild-type mice. The difference between
Mal)/) and wild-type bacterial burdens at these time-
points was < 05 log CFU/organ. Biologically, the rele-
vance of this increase in CFU is small when compared
with the increase of approximately 4 log CFU/organ
observed in the TLR4)/) and MyD88)/) mice by day 5.
TNF-a and NO production in response to
S. Typhimurium infection are deficient in MyD88)/)
and TRIF)/) macrophages, but not in Mal)/)
macrophages
BMDMs from wild-type, MyD88)/), Mal)/) and TRIF)/)
mice were infected with S. Typhimurium, and TNF-a
production and iNOS activity were measured. S. Ty-
phimurium infection stimulated the production of TNF-a
from wild-type BMDMs, whilst the levels of this cytokine
were very low in BMDMs from MyD88)/) or TRIF)/)
mice (Fig. 3a). NO production was also negligible in
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Figure 2. Bacterial counts after intravenous infection of mice with
1 · 103 colony-forming units (CFU) per mouse of Salmonella enteri-
ca serovar Typhimurium (S. Typhimurium) strain M525P. Mice
were killed by cervical dislocation, bacterial loads were determined in
the liver and the results are expressed as log CFU per organ for each
mouse with the mean marked by a bar. Wild-type (WT), MyD88)/)
(n = 3) (a), TIR-domain-containing adaptor-inducing interferon-
b)/) (TRIF)/)) (b and d) (n = 4) and Mal)/) (n = 4) (c) mice were
infected and the graphs are representative of at least two separate
experiments, *P < 005, **P < 001, ***P < 0001. p.i., postinfection.
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macrophages from the MyD88)/) or TRIF)/) mice after
infection (Fig. 4b). BMDMs from Mal)/) mice showed
minimal TNF-a and NO production in response to LPS,
as expected (Fig. 3c), but in response to infection, the lev-
els of these inflammatory mediators were mostly equiva-
lent to those seen in infected wild-type BMDMs.
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Figure 3. Tumour necrosis factor-a (TNF-a) and nitric oxide (NO) production from MyD88)/), Mal)/) and TIR-domain-containing adaptor-
inducing interferon-b)/) (TRIF)/)) macrophages. Bone marrow-derived macrophages (BMDMs) from wild-type, MyD88)/), Mal)/) or TRIF)/)
mice were infected with Salmonella enterica serovar Typhimurium (S. Typhimurium) strain SL1344 at multiplicity of infections (MOIs) of 0:1,
1:1 or 10:1 (bacteria : cell). Supernatant samples were assayed by enzyme-linked immunosorbent assay (ELISA) for tumour necrosis factor-a
(TNF-a) 7 hr after infection (a) or analysed using the Griess reaction for nitrite accumulation 22 hr after infection (b). The results are expressed
as the mean ± standard deviation from at least four separate experiments, *P < 005, ***P < 0001. Wild-type and Mal)/) BMDMs were also
stimulated with increasing doses of lipopolysaccharide (LPS) from S. Typhimurium SL1344, and TNF-a and NO production were assayed 7 and
22 hr after stimulation, respectively (c).
 2009 Blackwell Publishing Ltd, Immunology, 128, 472–483 477
TLR4 signalling in Salmonella infection
The defective pro-inflammatory response of TRIF)/)
macrophages to S. Typhimurium infection in vitro
is compensated for by IFN-c production in vivo
TNF-a is one of the inflammatory proteins critical for
successfully achieving a plateau in bacterial growth in sub-
lethal S. Typhimurium infection of mice.2 It is therefore
surprising that the TRIF)/) mice controlled a sublethal
S. Typhimurium infection despite their defective macro-
phage TNF-a response. IFN-c is elevated during bacterial
infections and enhances LPS-induced macrophage
responses, including the production of TNF-a.28 To deter-
mine whether IFN-c priming was able to restore inflamma-
tory responsiveness to TRIF)/) BMDM in vitro, the cells
were pretreated with IFN-c for 1 hr before infection with
S. Typhimurium. TRIF)/) BMDM now produced levels of
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TNF-a and NO similar to those produced by unprimed
wild-type BMDM (Fig. 4c and data not shown). Infected
TRIF)/) mice showed higher bacterial burdens than the
wild-type mice, and IFN-c levels increased with increasing
bacterial burden,29 so we measured the levels of IFN-c in
these animals after infection. Splenocytes from day 4 of an
infection in TRIF)/) mice showed enhanced levels of IFN-c
in comparison to control animals when re-infected ex vivo
with S. Typhimurium (Fig. 4a). Therefore, the increased
capability of splenocytes from infected TRIF)/)mice to pro-
duce IFN-c may be sufficient to up-regulate cytokine pro-
duction in vivo and allow the control of bacterial growth. As
IFN-c priming of TRIF)/) macrophages restored their abil-
ity to produce TNF-a in response to Salmonella infection in
vitro, we measured TNF-a production from the splenocytes.
Splenocytes from uninfected TRIF)/)mice produced signif-
icantly less TNF-a than wild-type splenocytes when
re-infected ex vivo. Splenocytes from infected TRIF)/) mice
were still deficient in TNF-a production 6 hr after re-infec-
tion, but by 24 hr after re-infection these cells were produc-
ing wild-type levels of TNF-a (Fig. 4b). These data suggest
that IFN-c restores the ability of the TRIF)/) cells to induce
a pro-inflammatory response, probably explaining why
these mice can control bacterial growth in vivo.
Neutrophil recruitment to lesions is defective in
infected TRIF)/) mice
The reduced bacterial killing in the TRIF)/) mice, and the
fact that TRIF has been linked to neutrophil recruitment
in bacterial lung infections,30–32 suggested that these ani-
mals may be defective in neutrophil recruitment during a
Salmonella infection. Hepatic histological analysis on day
7, a time-point when the plateau is well established,
showed that both wild-type and TRIF)/) mice had small,
well-demarcated focal infiltrates of neutrophils and mac-
rophages, interspersed by hepatocytes with pyknotic
nuclei and scattered small deposits of fragmented nuclear
debris. Some of the larger lesions had a central area of
necrosis, surrounded by a rim of inflammatory cells (pre-
dominantly containing moderate numbers of neutrophils
and lymphocytes and small numbers of macrophages)
(Fig. 4d). The TRIF)/) mice, on qualitative assessment,
had smaller lesions that appeared to be more frequent
(P = 008). By contrast, the wild-type animals had a smal-
ler number of generally larger lesions, with a qualitatively
higher proportion of neutrophils. These data suggest a
deficit in neutrophil function in TRIF)/) mice.
Absence of signalling through TLR4 does not hinder
the initiation of clearance of S. Typhimurium from
the organs
Following control by the host of bacterial growth in a
sublethal infection, S. Typhimurium will eventually be
cleared predominantly through the activity of CD4+ T
cells. To study the clearance phase of infection in TLR4)/)
mice requires the use of an attenuated bacterial strain
because these animals are unable to control the growth of
fully virulent S. Typhimurium. We therefore infected
these mice with S. Typhimurium SL3261, a mutant that
causes slowly progressing lethal infections if the animals
fail to mount T-cell immunity.22 Bacterial counts were
1–2 log higher in TLR4)/) mice compared with wild-type
mice; hence, we decided to inoculate 10-fold fewer bacte-
ria into the TLR4)/) mice than into the wild-type mice to
achieve similar bacterial loads. Surprisingly, we found that
TLR4)/) mice could initiate bacterial clearance, albeit at a
higher bacterial load than in wild-type mice (Fig. 5a).
Similar results were seen in MyD88)/) mice (Fig. 5b).
The Mal)/) and TRIF)/) mice were able to control the
growth of the virulent M525P strain, and therefore this
strain was used for clearance studies in these mice. Mal)/)
mice infected with M525P initiated clearance of
S. Typhimurium (Fig. 5d). TRIF)/) mice were also able
to start clearing the M525P strain of S. Typhimurium,
although this process appeared to be defective compared
with that in wild-type and Mal)/)mice, as a large varia-
tion in the rate of clearance was observed between mice
(Fig. 5c), and the TRIF)/) mice continued to have signifi-
cantly higher (P < 001) bacterial burdens than the wild-
type mice after initiation of clearance (at days 21, 28 and
35), as determined from the combined results of two
separate experiments.
Discussion
Here we showed that TLR4 signalling through MyD88,
but not through Mal or TRIF, is critically required to pro-
tect mice in a typhoid model of S. Typhimurium infec-
tion. TRIF is required for the early control of bacterial
growth during the first day of an intravenous infection
and for the pro-inflammatory response of macrophages to
infection. IFN-c priming of TRIF)/) macrophages restores
the ability of these cells to produce an inflammatory
response to infection, and splenocytes from infected
TRIF)/) mice produce high levels of this cytokine, which
may explain why TRIF)/) mice can control bacterial
growth in vivo. TLR2 plays little or no role in the control
of bacterial growth in the sublethal mouse typhoid model.
TLR signalling is not required for initiating the clearance
phase of mouse typhoid, as shown by the presence of
normal clearance patterns in MyD88)/) mice.
TLR4 and MyD88 are important for the survival of
mice after lethal infection with S. Typhimurium.8 Here
we used well-described sublethal models of S. Typhimuri-
um infection,33 where the bacterial counts obtained are
very consistent and show little variability, which allowed
us to follow the course of prolonged infection. The
immunological processes controlling bacterial growth in
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these models are well understood.2 We therefore explored
whether TLR4 modifies the antibacterial immune
response to S. Typhimurium infection. Bacterial growth
from day 1 onwards continued exponentially and failed
to plateau in TLR4)/) mice in comparison with wild-type
mice. These results are similar to those seen in sublethal
infection of the TLR4 mutant strain of mice, C3H/HeJ,5
confirming a key role for TLR4 in controlling systemic
infection with S. Typhimurium. In MyD88)/) mice, from
day 1 postinfection onwards, the exponential bacterial
growth was also unchecked, confirming that TLR4 signal-
ling through MyD88 is vital for controlling S. Typhimuri-
um growth in vivo. In both TLR4)/) and MyD88)/)
macrophages, as expected,6,8 the response to infection, as
measured by TNF-a and NO production, was almost
completely lost. These in vitro data are consistent with
the failure of the TLR4)/) and MyD88)/) mice to estab-
lish a plateau phase in bacterial growth in vivo, which is
dependent on the LPS-driven inflammatory response
induced by S. Typhimurium.5,34
MyD88 is essential for signalling through other TLRs,
including TLR2,12 and in lethal sepsis models TLR2
helps to protect the host against infection,10 but here, in
the sublethal mouse typhoid model, TLR2)/) mice
showed control of S. Typhimurium growth which was
similar to that seen in wild-type mice. These data sug-
gest that any role which TLR2 may play in protecting
the host against systemic Salmonella infections is second-
ary to the role of TLR4. In survival studies, TLR2)/)
mice showed a similar phenotype to wild-type mice, but
lower bacterial loads were seen in tissues from these ani-
mals.8 In our sublethal model, very similar spleen and
liver bacterial loads were seen in wild-type and TLR2)/)
mice, suggesting that TLR2 does not play a role in con-
trolling this type of infection. Differences in the role of
TLR2 in the host response to Salmonella infection seen
in our sublethal study and in the lethal salmonellosis
model used by us and by Weiss et al.,8 are probably the
result of a combination of elevated bacterial numbers
seen in the lethal model (increasing the availability of
TLR2 ligands produced by the bacteria) and the different
routes of infection used, leading to activation of differ-
ent cell types and/or different levels of TLR2 expressed.
To determine whether a role for TLR2 becomes appar-
ent at higher bacterial loads, we infected the TLR2)/)
mice with more bacteria, but again bacterial growth was
controlled in a manner similar to what is seen in wild-
type mice. We performed preliminary experiments in
TLR2)/) TLR4)/) mice to see if this would reveal a role
for TLR2 in sublethal S. Typhimurium infection, but the
results were very similar to those seen in TLR4)/) mice.
We concluded, therefore, that any role which TLR2 is
playing in the immune response to sublethal S. Typhimu-
ium infection is unlikely to be important in the control
of bacterial growth.
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Figure 5. Bacterial counts after intravenous infection of wild-type
(WT) mice [with 1 · 107 colony-forming units (CFU)/mouse] in com-
parison with toll-like receptor (TLR)4)/) (n = 3) (a) and MyD88)/)
(n = 4) (b) mice (with 1 · 106 CFU/mouse) of Salmonella enterica ser-
ovar Typhimurium (S. Typhimurium) SL3261, or intravenous infection
of wild-type, TIR-domain-containing adaptor-inducing interferon-b)/)
(TRIF)/)) (n = 3) (c) and Mal)/) (n = 4) (d) mice with 1 · 103 CFU
per mouse of S. Typhimurium M525P. Mice were killed by cervical dis-
location, bacterial loads were determined in the liver and the results are
expressed as log CFU per organ for each mouse with the mean marked
by a bar *P < 005, **P < 001, ***P <0001. p.i., postinfection.
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MyD88)/) mice are particularly susceptible to lethal
infection with S. Typhimurium, probably because of the
presence of a range of immune defects, including those
in cytokine production, in the development of Th1-type
responses, in NADPH oxidase activation, in phagocytic
capacity, and in IL-1 and IFN-c signalling.8,35–37 In this
study we have shown that, predictably, MyD88 plays a
central role in host protection in a mouse typhoid
model of infection. This is probably mostly through
TLR4 stimulation, given that very similar data were
seen in the MyD88)/) and TLR4)/) mice. The redun-
dancy of Mal in the typhoid model is a particular sur-
prise. Mal is required to bridge MyD88 and TLR438
and here we see a defective response of Mal)/) macro-
phages to LPS, but not to S. Typhimurium. Our studies
in vivo showed that Mal)/) mice behaved like wild-type
mice in response to S. Typhimurium infection. The lack
of a role for Mal in the control of S. Typhimurium is
similar to that seen in another study.39 These authors
suggested that mice lacking Mal accelerate the clearance
phase of infection compared with wild-type mice. In
our work, Mal played no role in the plateau or clear-
ance phases of S. Typhimurium infection. It is unclear
why Mal, which is important in some lung infection
models,30,40,41 is redundant in systemic S. Typhimurium
infection. Potentially, Mal may be more important in
controlling mucosal infections, rather than systemic
infections or a Salmonella protein; for example, one of
the newly identified Toll–interleukin-1 receptor domain
proteins42–44 may compensate for the lack of Mal. The
lack of Mal-dependency in our data, except at low
MOIs in vitro, is puzzling. It may be that at low MOIs
Mal sensitizes the MyD88 signalling pathway, but at
higher MOIs Mal is no longer required for full activa-
tion of MyD88-dependent signaling. In vivo our data
would therefore suggest that there are sufficient num-
bers of bacteria present to drive a Mal-independent
response. An alternative explanation for our data would
be that a protein produced by Salmonella may compen-
sate for the lack of Mal. At low MOIs of Salmonella
the levels of this protein may be insufficient to com-
pensate for the lack of Mal in terms of TNF-a produc-
tion. At the higher MOI there may be enough of the
Salmonella protein to allow full TNF-a production,
similar to that seen from wild-type cells.
TLR4 activation of TRIF signalling is linked to the gener-
ation of a Th1 response to LPS.35,45 In our study, TLR4 sig-
nalling through TRIF was required for controlling the early
growth of S. Typhimurium in vivo, but despite the fact that
macrophages from these mice are defective in inflammatory
responses to infection, these mice control bacterial growth.
Mice with elevated bacterial loads produce more IFN-c29
and in the present study we saw that infected TRIF)/) mice
had elevated levels of this cytokine. In BMDMs from these
mice, IFN-c restored cytokine production in response to
infection, and the enhanced production of IFN-c in S. Ty-
phimurium-infected TRIF)/) mice probably explains why
they can control bacterial growth in vivo. IFN-c signals via
the JAK/signal transducer and activator of transcription
[janus tyrosine kinase (JAK)/STAT] pathway, and STAT-
binding sites have been recognized in the promoter regions
of various inflammatory mediators, including iNOS.46 LPS
and IFN-c synergize to increase the production of iNOS
and TNF-a;46,47 therefore, in the absence of TRIF-depen-
dent TLR4 signalling, the IFN-c driven activation of the
STAT pathway could compensate for the lack of TRIF-dri-
ven IFN-b production, thus leading to full gene expression,
even in the absence of this signalling protein. IFN-c produc-
tion in response to Gram-negative bacterial infection is
TLR4 and MyD88 dependent10 and will not be generated in
the TLR4)/) and MyD88)/) mice. The elevated IFN-c levels
in TRIF)/) mice may be attributable to TRIF-dependent
TNF receptor associated factor (TRAF)3 signalling.
BMDMs from TRAF3-deficient mice lack IL-10 production
in response to LPS stimulation.48 IL-10 is a negative regula-
tor of IFN-c production49 and therefore the lack of this
cytokine may allow enhanced levels of IFN-c to accumulate
in the TRIF)/)mice.
TLR4 signalling through TRIF induces dendritic cell
maturation and may modulate NADPH-oxidase activa-
tion.12,50 In vivo, TRIF signalling contributes to the pro-
tection of mice against lung infections with Pseudomonas
aeruginosa and Escherichia coli.31,32 Infection of TRIF)/)
mice with S. Typhimurium, similarly to what is seen in
TLR4)/) mice, results in elevated bacterial numbers on
day 1 postinfection in both liver and spleen in compari-
son to wild-type mice. The normal reduction in bacterial
numbers on day 1 postinfection is dependent on bacterial
killing by neutrophils and macrophages through comple-
ment and NADPH-dependent reactive oxidase activity.2
TRIF is important for neutrophil recruitment in bacterial
lung infections31,32 and therefore it is likely that a failure
in neutrophil recruitment may account, to some extent,
for the elevated bacterial numbers seen in these mice.
Histological analysis of tissue obtained on day 7 of a
S. Typhimurium infection in TRIF)/) mice supports this
hypothesis, with a smaller proportion of neutrophils
present in the liver lesions compared with tissue from
wild-type mice. TLR4 co-operates sequentially with the
complement receptor C3 in neutrophil-driven killing of
Salmonella.51 It is therefore likely that the TLR4-depen-
dent decrease in bacterial numbers seen by day 1 postin-
fection is driven, in part, by the TRIF pathway via a
defect in both neutrophil and macrophage activities
through a TLR4/C3 mechanism.
Our study also investigated whether PRRs are required
to initiate clearance of S. Typhimurium infection, a pro-
cess that is dependent on the activity of CD4+ T cells.1
TLRs have been linked to successful activation of CD4+ T
cells52 and we expected to see a profound effect upon
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bacterial clearance in mice lacking TLR4-dependent signal-
ling. We found that bacterial clearance was initiated in
TLR4)/), MyD88)/), Mal)/) and TRIF)/) mice if they were
infected with a Salmonella strain that could be controlled
by the host in the initial phase of infection. Our data are
strikingly similar to early work in C3H/HeJ mice, which
clear an S. Typhimurium aroA mutant and generate full
protective immunity against virulent S. Typhimurium.53
By contrast, MyD88, whilst also not being important for
initiating bacterial clearance, is required for protective
immunity against S. Typhimurium.54 MyD88, in addition
to being recruited to most TLRs, is an adapter in the sig-
nalling pathway for induction of IL-1b and IL-18,12 and is
important in IFN-c signalling.36 Protective immunity to
S. Typhimurium may either be generated by a TLR other
than TLR4 or by a nucleotide oligomerisation domain
(NOD)-like receptor that induces IL-18 (a cytokine impor-
tant in protection against this pathogen.55) Our data sug-
gest that initiation of bacterial clearance, a process
dependent on the successful activation of CD4+ T cells,
does not require TLR4- or MyD88-dependent signalling,
yet protective immunity, which is independent of TLR4,
does require MyD88. To reconcile these observations, we
now therefore need to determine the contribution of PRRs
to the different mechanisms of protective immunity
against S. Typhimurium.
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